Prothrombin Time
"Prothrombin Time" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Clotting time of PLASMA recalcified in the presence of excess TISSUE THROMBOPLASTIN. Factors measured are FIBRINOGEN; PROTHROMBIN; FACTOR V; FACTOR VII; and FACTOR X. It is used for monitoring anticoagulant therapy with COUMARINS.
Descriptor ID |
D011517
|
MeSH Number(s) |
E01.370.225.625.115.610 E05.200.625.115.610 G09.188.680
|
Concept/Terms |
Prothrombin Time- Prothrombin Time
- Prothrombin Times
- Time, Prothrombin
- Times, Prothrombin
|
Below are MeSH descriptors whose meaning is more general than "Prothrombin Time".
Below are MeSH descriptors whose meaning is more specific than "Prothrombin Time".
This graph shows the total number of publications written about "Prothrombin Time" by people in this website by year, and whether "Prothrombin Time" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 1 | 1 | 2 | 1997 | 0 | 1 | 1 | 1999 | 0 | 1 | 1 | 2000 | 1 | 0 | 1 | 2003 | 0 | 2 | 2 | 2005 | 0 | 1 | 1 | 2006 | 0 | 2 | 2 | 2008 | 0 | 1 | 1 | 2012 | 0 | 2 | 2 | 2014 | 0 | 1 | 1 | 2019 | 0 | 1 | 1 | 2020 | 0 | 3 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Prothrombin Time" by people in Profiles.
-
Reinecke I, Solms A, Willmann S, Spiro TE, Peters G, Weitz JI, Mueck W, Garmann D, Schmidt S, Zhang L, Fox KAA, Berkowitz SD. Associations between model-predicted rivaroxaban exposure and patient characteristics and efficacy and safety outcomes in the prevention of venous thromboembolism. J Thromb Thrombolysis. 2020 Jul; 50(1):12-19.
-
Solms A, Willmann S, Reinecke I, Spiro TE, Peters G, Weitz JI, Mueck W, Garmann D, Schmidt S, Zhang L, Fox KAA, Berkowitz SD. Associations between model-predicted rivaroxaban exposure and patient characteristics and efficacy and safety outcomes in the treatment of venous thromboembolism. J Thromb Thrombolysis. 2020 Jul; 50(1):1-11.
-
Zhang L, Yan X, Fox KAA, Willmann S, Nandy P, Berkowitz SD, Hermanowski-Vosatka A, Weitz JI, Solms A, Schmidt S, Patel M, Peters G. Associations between model-predicted rivaroxaban exposure and patient characteristics and efficacy and safety outcomes in patients with non-valvular atrial fibrillation. J Thromb Thrombolysis. 2020 Jul; 50(1):20-29.
-
Solms A, Frede M, Berkowitz SD, Hermanowski-Vosatka A, Kubitza D, Mueck W, Spiro TE, Willmann S, Yan X, Zhang L, Garmann D. Enhancing the Quality of Rivaroxaban Exposure Estimates Using Prothrombin Time in the Absence of Pharmacokinetic Sampling. CPT Pharmacometrics Syst Pharmacol. 2019 11; 8(11):805-814.
-
Richardson R, Todd JM, Sharkey LC, Washabau RJ, Williams KD, Little KJ, Rendahl A. Retrospective characterization of canine coagulopathies using the turbidimetric ACL-TOP 300 analyzer (2014-2015): Forty-seven dogs. J Vet Emerg Crit Care (San Antonio). 2018 Nov; 28(6):551-558.
-
Sharkey LC, Little KJ, Williams KD, Todd JM, Richardson R, Gwynn AD, Rendahl A. Performance characteristics of the turbidimetric ACL-TOP CTS 300 coagulation analyzer in dogs and cats. J Vet Emerg Crit Care (San Antonio). 2018 Jul; 28(4):317-325.
-
Levi M, Moore KT, Castillejos CF, Kubitza D, Berkowitz SD, Goldhaber SZ, Raghoebar M, Patel MR, Weitz JI, Levy JH. Comparison of three-factor and four-factor prothrombin complex concentrates regarding reversal of the anticoagulant effects of rivaroxaban in healthy volunteers. J Thromb Haemost. 2014 Sep; 12(9):1428-36.
-
Lu BR, Zhang S, Narkewicz MR, Belle SH, Squires RH, Sokol RJ. Evaluation of the liver injury unit scoring system to predict survival in a multinational study of pediatric acute liver failure. J Pediatr. 2013 May; 162(5):1010-6.e1-4.
-
Lyle CA, Gibson E, Lovejoy AE, Goldenberg NA. Acute prognostic factors for post-thrombotic syndrome in children with limb DVT: a bi-institutional cohort study. Thromb Res. 2013 Jan; 131(1):37-41.
-
Shneider BL, Abel B, Haber B, Karpen SJ, Magee JC, Romero R, Schwarz K, Bass LM, Kerkar N, Miethke AG, Rosenthal P, Turmelle Y, Robuck PR, Sokol RJ. Portal hypertension in children and young adults with biliary atresia. J Pediatr Gastroenterol Nutr. 2012 Nov; 55(5):567-73.
|
People People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|